Financial Performance - The company's operating revenue for Q3 2025 was ¥61,539,411.55, a decrease of 13.79% compared to the same period last year[3] - The total profit for the period was -¥5,706,377.81, with a net profit attributable to shareholders of -¥4,211,492.36[3] - Year-to-date revenue reached ¥201,121,659.33, reflecting a significant increase of 49.84% year-on-year[3] - The basic earnings per share for the current period was -¥0.03, compared to ¥0.02 in the same period last year[3] - The net profit for the first three quarters of 2025 was ¥1,468,301.62, a recovery from a net loss of ¥18,943,044.54 in the same period of 2024[18] - The profit attributable to shareholders of the parent company for the first three quarters of 2025 was ¥2,425,401.00, compared to a loss of ¥15,218,361.67 in 2024[19] - The company reported a total comprehensive income of ¥1,466,872.73 for the first three quarters of 2025, compared to a loss of ¥18,950,151.39 in 2024[19] - The basic and diluted earnings per share for the first three quarters of 2025 were both ¥0.02, recovering from a loss of ¥0.10 per share in the same period of 2024[19] Research and Development - Research and development expenses totaled ¥5,807,306.57, down 12.56% from the previous year, while the R&D expense ratio to operating revenue increased by 9.44%[4] - Research and development expenses for the first three quarters of 2025 were ¥16,726,139.51, down from ¥22,158,393.96 in 2024, indicating a reduction of approximately 24.6%[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,455,337,049.01, representing a 5.90% increase from the end of the previous year[4] - Total current assets as of September 30, 2025, amount to ¥1,068,149,513.98, an increase from ¥1,009,925,202.93 at the end of 2024[14] - Total assets as of September 30, 2025, are ¥1,455,337,049.01, compared to ¥1,374,229,932.08 at the end of 2024[15] - Total current liabilities increased to ¥293,275,884.90 from ¥194,499,767.25 in the previous period[15] - The total liabilities as of the latest reporting period were ¥310,231,741.03, compared to ¥204,790,896.90 in the previous year, showing an increase of about 51.3%[16] - The total equity attributable to shareholders of the parent company was ¥1,144,816,311.34, a slight decrease from ¥1,169,503,243.59 in the previous year[16] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥137,747,827.02[3] - Operating cash inflow totaled $415,219,002.12, an increase from $240,821,027.27 in the previous period, reflecting a significant improvement in operational efficiency[22] - The net cash flow from operating activities was $137,747,827.02, a significant recovery from a negative cash flow of -$13,664,974.87 in the previous period[22] - The company reported a total cash inflow from investment activities of $2,029,286,581.19, slightly up from $2,018,862,008.98, indicating stable investment performance[22] Shareholder Information - Total number of common shareholders at the end of the reporting period is 6,437[11] - The largest shareholder, Huang Wenjun, holds 24,400,047 shares, representing 16.48% of total shares[12] - The company has no significant changes in the shareholder structure or related party transactions during the reporting period[12] Investment and Expenditures - Cash paid for purchasing fixed assets and other long-term assets was $27,947,432.74, down from $40,856,405.46, reflecting a reduction in capital expenditures[22] - The company paid $29,321,285.00 in dividends and interest, a decrease from $51,076,192.06, indicating a potential shift in dividend policy[23] Other Financial Metrics - Non-recurring gains and losses for the current period totaled ¥4,045,506.36, with government subsidies contributing significantly to this figure[6] - The weighted average return on equity decreased to -0.37% for the current period, down from 1.45% in the previous year[3] - The company's cash and cash equivalents are reported at ¥197,088,504.29, down from ¥502,392,537.69[14] - Accounts receivable decreased to ¥135,702,604.51 from ¥165,545,278.26[14] - Inventory increased to ¥99,639,491.83 from ¥70,746,455.45[14] - Long-term equity investments rose to ¥18,933,648.89 from ¥13,670,200.89[14] - The impact of exchange rate changes on cash and cash equivalents was minimal, with a positive effect of $57.82 compared to a negative impact of -$16,008.58 previously[23]

Financial Performance - The company's operating revenue for the third quarter was ¥147,025,041.89, a decrease of 3.02% compared to the same period last year[4] - The total profit for the quarter was ¥14,317,351.83, down 56.89% year-on-year[4] - The net profit attributable to shareholders was ¥8,056,002.34, reflecting a decline of 66.99% compared to the previous year[4] - The basic earnings per share for the quarter were ¥0.016875, a decrease of 66.99% year-on-year[5] - The net profit attributable to shareholders for the year-to-date was ¥35,434,588.41, down 31.32% compared to the same period last year[4] - Total operating revenue for the first three quarters of 2025 was CNY 419,308,487.51, a decrease of 3.3% compared to CNY 434,879,738.06 in the same period of 2024[23] - Net profit for the first three quarters of 2025 was CNY 40,634,818.79, down 30.9% from CNY 58,900,566.29 in the previous year[24] - Operating profit decreased to CNY 56,300,560.63, a decline of 27.7% compared to CNY 77,869,632.08 in the same period last year[24] - Basic earnings per share for the first three quarters of 2025 was CNY 0.07, compared to CNY 0.11 in the same period of 2024[25] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,081,871,943.27, representing a decrease of 7.97% from the end of the previous year[5] - Total assets amounted to CNY 2,081,871,943.27, a decrease from CNY 2,262,080,851.53 in the previous year[21] - Total liabilities decreased to CNY 276,356,658.83 from CNY 479,761,025.22 year-over-year[21] - Shareholders' equity increased to CNY 1,805,515,284.44, up from CNY 1,782,319,826.31 in the previous year[21] Cash Flow - The cash flow from operating activities for the year-to-date was ¥308,406,856.91, a decrease of 14.95%[4] - Cash inflow from operating activities for the first three quarters of 2025 was $907.64 million, compared to $972.45 million in the same period of 2024, representing a decrease of approximately 6.67%[27] - Net cash flow from operating activities for the first three quarters of 2025 was $308.41 million, down from $362.61 million in 2024, indicating a decline of about 14.93%[27] - Cash inflow from investment activities in the first three quarters of 2025 totaled $1.47 billion, significantly higher than $112.21 million in 2024, marking an increase of approximately 1215.56%[28] - Net cash flow from investment activities for the first three quarters of 2025 was -$320.67 million, compared to -$231.79 million in 2024, reflecting a worsening of about 38.38%[28] - Cash inflow from financing activities in the first three quarters of 2025 was $14.41 million, down from $43.17 million in 2024, a decrease of approximately 66.61%[28] - Net cash flow from financing activities for the first three quarters of 2025 was -$88.04 million, compared to -$131.81 million in 2024, showing an improvement of about 33.24%[28] - The ending cash and cash equivalents balance for the first three quarters of 2025 was $255.99 million, slightly lower than $265.50 million in 2024, a decrease of about 3.67%[28] Shareholder Information - Total number of common shareholders at the end of the reporting period is 33,975[12] - The largest shareholder, Shanghai Shentong Metro Group Co., Ltd., holds 278,943,799 shares, accounting for 58.43% of total shares[12] Government Subsidies and Legal Matters - The company received government subsidies amounting to ¥3,036,912.40, primarily related to commercial factoring[7] - The company has initiated legal proceedings against Shanghai Shishi Financing Leasing Co., Ltd. and has received favorable judgments in the first and second instances[14] Subsidiary Performance - The company's consolidated subsidiaries reported revenue of 19,210.72 million RMB and a net profit of 628.98 million RMB for the reporting period[17] - The company’s fully-owned subsidiary, the New Energy Company, reported revenue of 3,822.11 million RMB and a net profit of 1,505.26 million RMB[17] Future Plans - The company plans to distribute a cash dividend of 0.18 RMB per 10 shares, totaling approximately 8,592,874.29 RMB, which represents 31.39% of the net profit attributable to shareholders for the first half of 2025[15] - The company has decided to terminate the establishment of a joint venture named Shanghai Aiguan Intelligent Transportation Technology Co., Ltd.[15] Research and Development - Research and development expenses rose to CNY 2,305,444.86, an increase of 53.2% from CNY 1,503,896.92 in the previous year[23] Financial Expenses - Financial expenses decreased significantly to CNY 1,318,123.27, down 77.3% from CNY 5,810,709.33 year-over-year[23]

Financial Performance - The company's operating revenue for Q3 2025 was ¥2,092,309,132.74, a decrease of 7.01% compared to the same period last year[5] - The net profit attributable to shareholders for Q3 2025 was ¥28,227,823.03, down 25.62% year-on-year[5] - The total profit for Q3 2025 was ¥40,982,939.36, reflecting a decline of 13.23% compared to the previous year[5] - Total operating revenue for the first three quarters of 2025 was CNY 6,548,882,996.02, a decrease of 2.77% compared to CNY 6,735,206,324.77 in the same period of 2024[80] - Net profit for the first three quarters of 2025 was CNY 100,575,339.20, an increase of 2.18% compared to CNY 98,371,124.29 in 2024[81] Assets and Liabilities - The company reported a decrease in total assets to ¥9,739,539,927.47, down 8.32% from the end of the previous year[6] - Total current liabilities increased by 34.50% to approximately ¥2.16 billion, driven by increased short-term borrowings and bank acceptance bill financing[26] - The company's total liabilities decreased to CNY 7,114,767,220.73 in 2025 from CNY 7,842,700,401.71 in 2024, representing a reduction of 9.26%[80] - The total equity attributable to shareholders decreased to CNY 2,626,079,923.78 in 2025 from CNY 2,797,247,891.58 in 2024, a decline of 6.12%[80] Cash Flow - The company achieved a net cash flow from operating activities of ¥822,365,008.82 for the year-to-date, an increase of 63.79%[6] - Cash inflow from operating activities for the first three quarters of 2025 was CNY 6,664,555,989.57, down from CNY 7,020,499,902.81 in 2024, a decrease of 5.08%[84] - The net cash flow from operating activities was $822,365,008.82, an increase from $502,088,314.28 in the previous period, reflecting a growth of approximately 63.8%[85] Revenue Structure - The proportion of medical insurance settlement income in the company's main business revenue decreased from 52% in 2022 to 40% in 2025[8] - The company has shifted its revenue structure, with prescription drug revenue decreasing by 1.75% and non-prescription drug revenue increasing by 1.75%[10] - Prescription drug revenue decreased by 6.46% year-on-year, while non-prescription drug revenue increased by 2.52%, reflecting the company's efforts to reduce reliance on prescription drugs[47] Cost Management - The company has implemented cost control measures, resulting in a 6.67% decrease in period expenses in Q3 2025 compared to the same period last year[10] - The company has implemented measures to control costs, resulting in a 2.84% year-on-year decrease in period expenses for the first nine months of 2025[21] - The company has initiated negotiations to reduce rental costs, focusing on high-rent, low-output stores to improve overall cost structure[21] Inventory Management - The company has significantly reduced inventory value by CNY 726.82 million, achieving a 23.24% decrease compared to the beginning of the year, enhancing inventory turnover efficiency[15] - The company's inventory stock increased by 48.70% to approximately ¥145.44 million, influenced by the stock repurchase plan approved by the board[26] - Inventory decreased to approximately ¥2.40 billion from ¥3.13 billion, reflecting enhanced inventory turnover efficiency[78] Store Operations - The company closed 83 stores and opened 45 new stores in the first nine months of 2025, resulting in a net decrease of 38 stores, bringing the total to 5,448 stores[36] - The company faced challenges in expanding its store network due to high rents and regulatory constraints, leading to a strategic adjustment in its expansion pace[36] - The company is focusing on optimizing existing stores and addressing high-loss locations through strategic relocations[36] Shareholder Information - The total number of common shareholders at the end of the reporting period is 15,091[33] - The top 10 shareholders hold a total of 84,000,000 shares, representing 55.36% of the total shareholding[33] - Shenzhen Changsi Xing Industrial Development Co., Ltd. is the largest shareholder, holding 23,439,968 shares, which is 15.17% of the total[33] Compliance and Regulations - The company has established a comprehensive compliance system for medical insurance operations, enhancing training and assessment for relevant departments[18] - The company is actively working on compliance with regulatory bodies to improve drug supervision and insurance compliance levels[71] Strategic Initiatives - The company is focusing on enhancing store efficiency and transforming its business model to adapt to market changes and consumer needs[13] - The company is focusing on transforming its business model to emphasize professional pharmaceutical services and health management, moving away from reliance on insurance sales[69] - A strategic focus on high-quality innovation and category management is expected to drive sales growth and improve operational efficiency[74]

Financial Performance - The company's operating revenue for Q3 2025 reached ¥46,176,924,934.12, representing a year-on-year increase of 9.43%[3] - Total profit for the period was ¥2,514,508,079.68, reflecting a significant growth of 25.14% compared to the same period last year[3] - Net profit attributable to shareholders was ¥1,804,288,696.31, up by 12.01% year-on-year[3] - Total operating revenue for the first three quarters of 2025 reached ¥130.85 billion, an increase of 9.8% compared to ¥119.49 billion in the same period of 2024[17] - Operating profit for the first three quarters of 2025 was ¥6.21 billion, up from ¥5.47 billion in 2024, reflecting a growth of 13.6%[17] - Net profit attributable to shareholders of the parent company for the first three quarters of 2025 was ¥4.69 billion, compared to ¥4.47 billion in 2024, representing a year-on-year increase of 4.8%[18] - The total comprehensive income for the first three quarters of 2025 was ¥5.91 billion, up from ¥5.34 billion in 2024, reflecting an increase of 10.6%[18] - Basic earnings per share for the first three quarters of 2025 were ¥1.487, compared to ¥1.419 in 2024, indicating a growth of 4.8%[18] Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date period was ¥9,977,266,495.23, showing a substantial increase of 77.56%[3] - The company reported a cash inflow from operating activities of ¥92.57 billion in the first three quarters of 2025, compared to ¥93.66 billion in the same period of 2024[20] - Total cash inflow from operating activities was ¥94,243,577,627.94, slightly down from ¥95,734,987,361.84, reflecting stable operational cash generation[21] - Cash and cash equivalents at the end of the period reached ¥39,297,455,628.68, up from ¥33,755,991,302.93, reflecting a strong liquidity position[22] - The company received cash from borrowings amounting to ¥6,326,687,065.01, slightly down from ¥6,422,381,856.57, indicating stable borrowing levels[22] - The company paid out ¥3,855,579,366.41 in dividends and interest, an increase from ¥3,085,645,138.66, indicating a commitment to returning value to shareholders[22] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥198,243,635,482.10, marking a 7.16% increase from the end of the previous year[4] - Total liabilities increased to ¥129.68 billion in 2025 from ¥118.89 billion in 2024, marking a rise of 9.8%[14] - The company's total equity rose to ¥68.56 billion in 2025, up from ¥66.12 billion in 2024, indicating a growth of 3.7%[14] - As of September 30, 2025, the total current assets of Huayu Automotive Systems Co., Ltd. amounted to RMB 131.22 billion, an increase from RMB 118.03 billion as of December 31, 2024, representing a growth of approximately 11.2%[12] - The total assets of the company as of September 30, 2025, were RMB 198.24 billion, compared to RMB 185.01 billion at the end of 2024, marking an increase of around 7.1%[13] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 61,471[9] - Shanghai Automotive Group Co., Ltd. held 58.32% of the shares, making it the largest shareholder[10] - The company has not disclosed any significant changes in shareholder relationships or actions regarding the top 10 shareholders[11] Operational Highlights - The increase in total profit was primarily driven by revenue growth leading to higher gross margins[8] - Research and development expenses for the first three quarters of 2025 were ¥4.70 billion, slightly higher than ¥4.57 billion in 2024, showing an increase of 2.8%[17] - The total operating costs for the first three quarters of 2025 were ¥127.49 billion, an increase of 9.4% from ¥116.53 billion in 2024[17] - The company reported a significant increase in other receivables, which rose to RMB 3.10 billion from RMB 2.42 billion, reflecting a growth of approximately 28.1%[12] Investment Activities - Total cash inflow from investment activities was ¥2,855,044,576.65, compared to ¥1,758,101,059.48 previously, indicating improved investment returns[21] - Cash outflow from investment activities totaled ¥2,856,962,532.91, a decrease from ¥10,124,951,211.14, suggesting a reduction in capital expenditures[21] Exchange Rate Impact - The impact of exchange rate changes on cash and cash equivalents was positive at ¥26,506,581.79, contrasting with a negative impact of -¥4,399,225.23 previously[22]

Financial Performance - The company's operating revenue for Q3 2025 was ¥2,042,719,648.45, a decrease of 22.43% year-on-year[5] - The total profit for the period was ¥190,562,105.19, down 48.54% compared to the same quarter last year[5] - Net profit attributable to shareholders was ¥129,104,688.63, reflecting a decline of 45.31% year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥102,282,542.35, a significant drop of 58.01% compared to the previous year[5] - The basic and diluted earnings per share were both ¥0.0963, down 45.28% year-on-year[5] - Total operating revenue for the first three quarters of 2025 was CNY 6.92 billion, a decrease of 19.5% compared to CNY 8.59 billion in the same period of 2024[20] - Net profit for the first three quarters of 2025 was CNY 933.23 million, a decline of 22.2% from CNY 1.20 billion in 2024[21] - Operating profit for the first three quarters of 2025 was CNY 1.10 billion, down 25.0% from CNY 1.47 billion in the previous year[21] - Basic earnings per share for the first three quarters of 2025 were CNY 0.5974, down from CNY 0.7117 in 2024[22] Assets and Liabilities - The company's total assets at the end of the reporting period were ¥19,330,801,003.68, a decrease of 3.13% from the end of the previous year[6] - The company's current assets totaled RMB 10,799,627,521.67, down from RMB 11,684,104,124.22, indicating a decrease of about 7.53%[16] - Total liabilities decreased to RMB 3,632,219,485.35 from RMB 4,633,633,097.68, a reduction of about 21.59%[17] - The company's equity attributable to shareholders increased to RMB 13,638,317,886.42 from RMB 13,203,924,172.51, an increase of approximately 3.29%[18] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥1,141,629,735.11, down 43.66% year-on-year[5] - Cash flow from operating activities generated CNY 1.14 billion, a decrease of 43.7% compared to CNY 2.03 billion in 2024[25] - The net cash flow from investment activities was negative at CNY 1.67 billion, worsening from a negative CNY 1.35 billion in 2024[25] - In the first three quarters of 2025, the net cash flow from financing activities was -$1.64 billion, compared to -$407.06 million in the same period of 2024[26] - The total cash outflow from financing activities in the first three quarters of 2025 was $1.64 billion, significantly higher than $457.06 million in 2024[26] Expenses - Total operating costs decreased to CNY 5.86 billion, down 18.0% from CNY 7.15 billion year-over-year[20] - Research and development expenses for the first three quarters of 2025 were CNY 331.63 million, a reduction of 20.3% from CNY 416.21 million in 2024[20] - Sales expenses significantly decreased to CNY 354.82 million, down 63.4% from CNY 969.12 million year-over-year[20] Market Factors - The decline in profits was attributed to industry cycles, market competition, and reduced demand for key products[9] - The company reported a significant increase in non-recurring gains and losses, impacting the net profit figures[10] Cash and Equivalents - Cash and cash equivalents decreased to RMB 4,141,241,012.60 from RMB 6,211,941,467.03, representing a decline of approximately 33.39%[15] - The cash and cash equivalents at the end of Q3 2025 were $3.99 billion, down from $5.42 billion at the end of Q3 2024[26] - The net increase in cash and cash equivalents for the first three quarters of 2025 was -$2.16 billion, while it was $289.39 million in the same period of 2024[26] - The impact of exchange rate changes on cash and cash equivalents was $18.64 million in 2025, compared to $24.55 million in 2024[26]

Financial Performance - The company's operating revenue for the third quarter reached ¥903,933,284.80, representing a year-on-year increase of 33.13%[4] - Net profit attributable to shareholders was ¥83,768,310.60, up 4.18% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥87,579,901.30, an increase of 33.18% year-on-year[4] - The basic earnings per share for the quarter was ¥0.21, reflecting a growth of 5.00% compared to the previous year[4] - Operating profit increased by 33.47% to approximately $299.76 million, attributed to higher sales profits[10] - Total profit rose by 33.30% to approximately $296.56 million, mainly due to increased sales profits[10] - Net profit for the current period was ¥257,099,061.84, representing a 27% increase from ¥202,061,878.48 in the previous period[23] - Operating profit increased to ¥299,756,948.77, compared to ¥224,587,974.66, marking a growth of about 33%[23] - The total comprehensive income attributable to the parent company was CNY 257,457,996.79, an increase from CNY 202,464,298.66 in the previous period, representing a growth of approximately 27.1%[24] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥7,475,596,315.49, a 4.99% increase from the end of the previous year[4] - The total assets of the company reached ¥7,475,596,315.49, compared to ¥7,120,328,881.57, reflecting a growth of approximately 5%[21] - Current liabilities totaled ¥1,697,853,853.07, an increase from ¥1,318,153,068.43, representing a growth of about 29%[21] - The company's total liabilities amounted to ¥2,720,991,330.07, up from ¥2,497,136,820.08, indicating an increase of approximately 9%[21] - The total equity attributable to shareholders was ¥4,761,480,177.58, reflecting a 2.85% increase from the previous year-end[4] - The total equity attributable to shareholders increased to ¥4,761,480,177.58 from ¥4,629,708,318.70, reflecting a growth of about 3%[21] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥207,162,024.22, showing a 35.16% increase[4] - Cash inflow from operating activities increased by 54.38% to approximately $2.96 billion, driven by higher bank deposit recoveries and sales receipts[10] - Net cash flow from operating activities was CNY 207,162,024.22, up from CNY 153,275,696.29, indicating a rise of about 35.1%[26] - Cash inflow from operating activities totaled CNY 2,960,413,417.18, compared to CNY 1,917,556,336.25 in the previous period, marking an increase of approximately 54.4%[26] - Cash flow from financing activities netted approximately $247.93 million, a significant increase of 440.85% due to increased bank loans[11] - Net cash flow from financing activities was CNY 247,931,551.04, a significant improvement from a net outflow of CNY 72,738,754.57 in the previous period[26] Shareholder Information - Total number of common shareholders at the end of the reporting period is 22,194[13] - The largest shareholder, Yang Pengwei, holds 41.71% of shares, totaling 170,474,412 shares[13] - The second largest shareholder, Yang Guowen, holds 10.57% of shares, totaling 43,200,000 shares[13] - The company repurchased 5,190,199 shares, accounting for 1.27% of the total share capital[14] - The total number of restricted shares held by Yang Pengwei is 127,855,809, which are locked due to executive restrictions[16] - The total number of restricted shares held by Yang Guowen is 32,400,000, also locked due to executive restrictions[16] - The company has a total of 162,601,521 restricted shares at the end of the period[17] - The company has not reported any changes in the participation of major shareholders in margin trading[15] Other Financial Metrics - Accounts receivable increased by ¥171,475,391.48, or 31.19%, primarily due to increased sales[9] - The company reported a significant increase in trading financial assets, which rose by 415.42% to ¥119,005,000.00, mainly due to an increase in bank wealth management products[9] - Prepayments increased by 122.25% to approximately $36.77 million, primarily due to an increase in advance payments for materials[10] - Inventory rose by 31.41% to approximately $354.63 million, mainly driven by capacity expansion[10] - Short-term borrowings surged by 3177.39% to approximately $655.48 million, primarily due to an increase in bank loans[10] - Tax expenses increased by 93.35% to approximately $39.47 million, primarily due to higher sales profits[10] - Other income rose by 130.34% to approximately $35.74 million, mainly from increased government subsidies[10] - Investment income decreased by 162.38% to approximately -$13.07 million, primarily due to losses from forward foreign exchange settlements and financial liabilities[10] Audit and Reporting - The third quarter financial report was not audited, which may impact the reliability of the reported figures[27]

Financial Performance - The company's operating revenue for Q3 2025 was CNY 2,573,902,918.58, representing a year-on-year increase of 2.15%[2] - The total profit for the period reached CNY 605,602,727.27, a significant increase of 181.40% compared to the same period last year[2] - The net profit attributable to shareholders was CNY 492,900,442.71, reflecting a year-on-year growth of 184.71%[2] - The basic earnings per share (EPS) for the quarter was CNY 0.325, up 185.09% from the previous year[2] - Total operating revenue for the first three quarters of 2025 reached CNY 7,821,981,737.44, an increase of 8.8% compared to CNY 7,187,635,233.88 in the same period of 2024[15] - Net profit for the first three quarters of 2025 was CNY 1,000,156,579.27, a significant increase of 80.2% compared to CNY 554,439,042.99 in 2024[16] - Earnings per share for the first three quarters of 2025 were CNY 0.637, compared to CNY 0.348 in the same period of 2024, representing an increase of 83.0%[16] - The company's total comprehensive income for the first three quarters of 2025 was RMB 869.0 million, compared to RMB 456.1 million in 2024, marking an increase of about 90.5%[26] Assets and Liabilities - Total assets at the end of the reporting period were CNY 13,364,155,868.66, an increase of 1.33% from the end of the previous year[2] - The equity attributable to shareholders rose to CNY 6,668,093,096.47, marking an 8.21% increase year-on-year[2] - Total current assets as of September 30, 2025, amount to RMB 6,120,312,102.78, a decrease from RMB 6,437,144,956.62 at the end of 2024[12] - Total liabilities decreased to CNY 6,448,124,290.71 from CNY 6,561,651,449.21, showing a reduction of 1.7%[14] - The company's total equity increased to CNY 6,916,031,577.95, up from CNY 6,627,126,500.82, marking a growth of 4.4%[14] Cash Flow - The company reported a 70.36% increase in net cash flow from financing activities, attributed to a higher net increase in bank loans[5] - The net increase in cash and cash equivalents was 112.05%, driven by reduced tax payments and increased cash flow from financing activities[5] - Operating cash flow for the first three quarters of 2025 reached ¥894,413,662.19, an increase of 17.8% compared to ¥759,320,221.06 in the same period of 2024[19] - Total cash inflow from operating activities was ¥8,634,228,333.23, slightly up from ¥8,618,473,718.56 year-over-year[19] - Cash outflow from operating activities totaled ¥7,739,814,671.04, down from ¥7,859,153,497.50 in the previous year[19] - The company reported a net cash flow from operating activities of -RMB 231.4 million for the first three quarters of 2025, compared to RMB 165.9 million in 2024, indicating a significant decline[28] Investments and Expenses - Non-recurring gains and losses for the period totaled CNY 270,616,943.74, with significant contributions from asset disposals and government subsidies[3] - Research and development expenses for the first three quarters of 2025 were CNY 260,925,563.36, slightly up from CNY 257,016,052.67 in 2024, indicating a year-on-year increase of 1.1%[15] - Investment income for the first three quarters of 2025 was CNY 348,938,016.67, a substantial increase from CNY 21,032,007.62 in 2024, reflecting a growth of 1,558.5%[15] - The company reported interest expenses of RMB 44.6 million for the first three quarters of 2025, a decrease from RMB 48.5 million in 2024, reflecting a reduction of approximately 8.0%[25] Shareholder Information - The total number of common shareholders at the end of the reporting period is 85,646[7] - Shanghai Zijiang (Group) Co., Ltd. holds 395,207,773 shares, accounting for 26.06% of total shares[7] - The company transferred 16,562,301 shares of Zijiang New Materials Technology Co., Ltd. for RMB 298.52 million, representing 27.89% of Zijiang New Materials' total shares[9] - The estimated increase in net profit from the share transfer is approximately RMB 240 million[11]

杭州博拓生物科技股份有限公司 2025 年第三季度报告 杭州博拓生物科技股份有限公司2025 年第三季度报告 证券代码：688767 证券简称：博拓生物 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 1 / 16 杭州博拓生物科技股份有限公司2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 | | | | 单位：元 | 币种：人民币 | | --- | --- | --- | --- | --- | | | | 本报告期比 | | 年初至报告期 | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | ...

Financial Performance - The company's revenue for Q3 2025 reached ¥757,634,691.91, representing a 53.11% increase compared to the same period last year[5] - Net profit attributable to shareholders was ¥20,482,188.26, a significant increase of 1,318.42% year-on-year[5] - The basic earnings per share (EPS) was ¥0.03, reflecting a 1,204.35% increase compared to the previous year[5] - Total operating revenue for the current period reached ¥1,446,085,256.60, an increase of approximately 31.5% compared to ¥1,099,954,746.80 in the previous period[17] - Net profit for the current period was reported at -¥20,009,954.19, an improvement from -¥74,837,906.64 in the previous period[18] - The total comprehensive income for the period was -20,926,608.97, compared to -74,978,044.64 in the previous period[19] - Basic and diluted earnings per share were both -0.07, an improvement from -0.15 in the previous period[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥9,250,388,558.83, a decrease of 0.77% from the end of the previous year[5] - The company’s total assets amounted to ¥9,250,388,558.83, slightly down from ¥9,321,828,929.45[16] - Current liabilities totaled ¥3,820,103,383.63, a decrease from ¥4,063,830,921.63[16] - Long-term borrowings increased to ¥1,529,793,829.55 from ¥1,265,798,354.81, indicating a rise of approximately 20.9%[16] - The company’s equity attributable to shareholders decreased to ¥3,303,180,044.57 from ¥3,410,606,939.56, a decline of about 3.1%[16] Cash Flow - The company reported a net cash flow from operating activities of -¥401,880,681.61, an improvement of 34.87% compared to the previous year[8] - The net cash flow from operating activities was -401,880,681.61, an improvement from -617,088,202.62 in the previous period[21] - The net cash flow from investing activities was -354,181,146.65, compared to -485,324,908.66 in the previous period, indicating a reduction in cash outflow[21] - The net cash flow from financing activities was 222,404,539.98, a significant decrease from 1,302,797,471.44 in the previous period[21] - Cash received from the sale of goods and services amounted to 1,344,352,085.97, up from 1,097,301,032.69 in the previous period, representing an increase of approximately 22.5%[20] - The total cash and cash equivalents at the end of the period were 1,167,305,913.60, compared to 1,083,478,219.03 in the previous period[21] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 48,620[10] - The company has a total of 14,508,530 shares held in the repurchase special securities account, representing 2.15% of total shares[12] - The top ten shareholders include Zhejiang Zhonghe Technology Co., Ltd. with 24,841,540 shares, accounting for 3.67% of total shares[11] - Zhejiang Yinwan Private Fund Management Co., Ltd. holds 11,166,620 shares through its Silver Wan Quan Ying 56 private equity fund, representing 1.65% of total shares[11] - The company has not reported any changes in the top ten shareholders due to securities lending or borrowing activities[13] - The total number of preferred shareholders and their holdings is not applicable for this report[13] Operational Metrics - The company experienced a 37.64% increase in operating costs, totaling ¥1,058,620,885.82, primarily due to the rise in revenue[8] - Total operating costs increased to ¥1,482,025,509.10, up from ¥1,172,534,165.22, reflecting a rise of about 26.4%[17] - Research and development expenses were reported at ¥139,612,946.35, slightly down from ¥142,928,541.87[18] - The company reported a significant increase in prepayments, which rose by 184.00% to ¥91,510,748.79, indicating increased procurement activities[8] Investment Income - The company’s investment income rose by 188.56% to ¥7,871,274.05, attributed to increased returns from joint ventures[8] - The company recorded an investment income of ¥7,871,274.05, a significant recovery from a loss of -¥8,888,437.42 in the previous period[18] - The company received 1,650,000.00 in cash from investment, a notable increase from 802,694,238.18 in the previous period[21] - The cash inflow from investment activities totaled 140,236,638.14, compared to 42,476,065.59 in the previous period, showing a significant increase[21] Other Financial Metrics - The company reported a cash balance of ¥1,310,232,016.56 at the end of the period, down from ¥1,869,384,119.43 at the beginning, indicating a decrease of approximately 30%[14] - Accounts receivable decreased to ¥1,003,913,067.96 from ¥1,084,999,980.23, reflecting a reduction of about 7.5%[14] - The company has no trading financial assets reported, down from ¥100,000,000.00 in the previous period[14] - The company’s accounts receivable financing decreased to ¥7,786,958.94 from ¥13,703,871.33, a decline of approximately 43.9%[14] - The company reported a foreign currency translation adjustment of -916,654.78, compared to -140,138.00 in the previous period[19]

安琪酵母股份有限公司 2025 年第三季度报告 证券代码：600298 证券简称：安琪酵母 安琪酵母股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 | | | 单位：元 | 币种：人民币 | | | --- | --- | --- | --- | --- | | | | 本报告期比 | 年初至报告期 | | | 项目 | 本报告期 | 上年同期增 年初至报告期末 | 末比上年同期 | | | | | 减变动幅度 | 增减变动幅度 | | | | | (%) | (%) | | | 营业收入 | 3,887,153,650.89 | 4.00 1 ...